Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Apply
Ziftomenib, FLAG-IDA, Low-Dose Cytarabine, Gilteritinib
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step